How have patient-centric approaches influenced regulatory changes?
Patient-centric approaches have increasingly influenced regulatory changes by involving patients in the drug development and approval processes. Initiatives like the FDA's Patient-Focused Drug Development (PFDD) program emphasize understanding the patient experience and incorporating their input into regulatory decisions. This ensures that the treatments approved not only meet clinical efficacy standards but also address the real-world needs and preferences of patients.
